Raymond Lansink
Tracked across 1 events · 6 articles · First seen Jun 01, 2026 · Last active Jun 16, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Raymond Lansink, a Board Member and Shareholder of QliniQ B.V., shared positive sentiments about the acquisition, emphasizing the potential for future growth and value creation with Marksans Pharma.
Jun 01, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Raymond Lansink live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard